Christina Kaiser

Christina Kaiser is a Senior Principal Scientist at Sobi - Swedish Orphan Biovitrum AB (publ) with a career spanning over two decades in the pharmaceutical industry. Since August 2011, Christina has been instrumental in Clinical & Translational Science, focusing on evaluating external pipeline assets, co-development, in-licensing, and acquisition. Christina also drives early preclinical projects and portfolio innovation while fostering new collaborations. Prior roles at Sobi included Principal Scientist in Non Clinical Safety & Pharmacology and earlier positions at Biovitrum AB, where Christina served as Senior Scientist leading the Cell Biology Team and as Research Scientist. Christina's academic background includes a PhD in Medical Sciences from Karolinska Institutet and a Master of Chemical Engineering from KTH Royal Institute of Technology.